NEW YORK, Nov. 09, 2020 (GLOBE NEWSWIRE) -- KBL Merger Corp. IV (NASDAQ: KBLM or the "Company"), a special purpose acquisition company (SPAC), today announced the successful completion of its acquisition...
NEW YORK, Nov. 06, 2020 (GLOBE NEWSWIRE) -- KBL Merger Corp. IV (NASDAQ: KBLM or the "Company"), a special purpose acquisition company (SPAC) that previously announced an agreement to acquire 180...
Clinical stage biotechnology company 180 Life Sciences Corp. , whose scientific teams are led by drug developers renowned for producing some of the largest-selling pharmaceuticals to ever come to market,...
KBL Merger Corp. (NASDAQ, KBLMKBL, KBLMR, KBLMW) (“KBL”), a special purpose acquisition company (“SPAC”) that previously announced the agreement to acquire 180 Life Sciences Corp. , today announced...
NEW YORK, Oct. 23, 2020 (GLOBE NEWSWIRE) -- NetworkNewsAudio – 180 Life Sciences Corp., a clinical-stage biotechnology company that has entered into a definitive merger agreement with KBL Merger Corp....
NEW YORK, Oct. 23, 2020 (GLOBE NEWSWIRE) -- KBL Merger Corp. IV (NASDAQ: KBLM or the "Company"), a special purpose acquisition company (SPAC) that previously announced an agreement to acquire 180...
NetworkNewsWire Editorial Coverage : Enormous amounts of money exchange hands in the big pharma space as companies merge and are acquired — all in search of the next blockbuster drug. While the discovery...
NEW YORK, Oct. 21, 2020 (GLOBE NEWSWIRE) -- via NetworkNewsWire — 180 Life Sciences Corp., a clinical-stage biotechnology company that has entered into a definitive merger agreement with KBL Merger...
KBL Merger Corp. (NASDAQ: KBLM), a special purpose acquisition company (“SPAC”) that previously announced the acquisition of 180 Life Sciences , was featured in a Seeking Alpha news article. The...
KBL Merger Corp. IV (NASDAQ: KBLM), a special purpose acquisition corporation (“SPAC”) that has signed a detailed merger agreement with 180 Life Sciences Corp. , announced that the company has continued...